Know Cancer

or
forgot password

Long-term Anastrozole Versus Tamoxifen Treatment Effects (LATTE)


N/A
18 Years
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Long-term Anastrozole Versus Tamoxifen Treatment Effects (LATTE)


Inclusion Criteria:



- patients randomised to one of the monotherapy arms in the ATAC Trial

- alive at 10 years follow-up

Exclusion Criteria:

- patients who have withdrawn consent to participate in the ATAC Trial or this study

- where the LATTE Executive Committee determines that there is no possibility of
obtaining follow-up

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Time to recurrence

Outcome Description:

Time to recurrence of breast cancer in the post 10 year period (defined as the earliest of local or distant recurrence, new primary breast cancer, or death)

Outcome Time Frame:

LATTE particpants who are 10 years post treatment will be followed for 5 years for the purpose of this study.

Safety Issue:

No

Principal Investigator

Robert Smith, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

American Cancer Society, Inc.

Authority:

United States: Institutional Review Board

Study ID:

IRB00050408

NCT ID:

NCT01745289

Start Date:

February 2013

Completion Date:

January 2018

Related Keywords:

  • Breast Cancer
  • Breast Cancer
  • Survival
  • Recurrence
  • Breast Neoplasms

Name

Location